Standard re-treatment regimen for TB ‘failing’ in developing worldMarch 16th, 2011 - 3:16 pm ICT by ANI
Washington, March 16 (ANI): A new study has revealed that the standard approach to re-treating tuberculosis (TB) in low and middle-income settings is failing.
Researchers have called for improved access to rapid diagnostics for drug resistant TB, second-line TB treatment and antiretroviral HIV therapy.
Each year, between one in ten and one in five patients treated for TB see their disease return after failing, interrupting or relapsing from treatment.
This results in an estimated one million people in 90 countries being treated with an 8 month long regimen of five drugs. The therapy has been in use for over three decades and is recommended by the World Health Organisation.
But the study in Kampala, Uganda, of 140 HIV-infected patients and 148 HIV-uninfected patients found that the re-treatment TB regimen failed to work effectively in a significant proportion of patients - 26 percent of HIV-infected patients and 20 percent of HIV-uninfected patients.
Nearly a quarter of patients died, whilst 6 percent saw their TB disease return. Fatalities were particularly high amongst HIV-infected patients.
“Our study suggests that the recommended therapy for re-treating TB is failing as many as one in four people with recurrent TB in the developing world,” said Edward Jones-Lopez, Assistant Professor of Medicine at Boston University School of Medicine.
The researchers believe that a number of reasons may be to blame. These include poor adherence to the drug regimen and the presence of drug-resistant forms of TB - including multi-drug resistant TB - some cases of which may have gone undiagnosed.
They call for improved access to rapid diagnostics for drug resistant TB, second-line TB treatment and antiretroviral HIV therapy.
The study has been published in the open access journal PLoS Medicine. (ANI)
- Patients with HIV infection at greater risk of developing heart failure - Apr 26, 2011
- Starting HIV treatment early preserves immune function - Sep 29, 2010
- HIV may be risk factor in heart failure - Apr 26, 2011
- US approves drug to prevent HIV infection - Jul 17, 2012
- Berlin 2010: TB, HIV and Lung Health: From research and innovation to solutions - Nov 02, 2010
- Liver-related problems found among Goa HIV patients: Study - Apr 20, 2011
- False diagnosis of TB in HIV patients is fatal - May 17, 2010
- Cancer drug successfully purges hidden HIV virus - Mar 09, 2012
- Low-cost pain killer can wipe out resistant TB, say researchers - Sep 13, 2012
- New findings on drug tolerance could help cure TB faster - Mar 04, 2011
- Central team to probe drug resistant TB cases in Mumbai - Jan 17, 2012
- Advance made in TB treatment - May 20, 2010
- Priority is to up collaborative TB-HIV activities - Jul 19, 2010
- Aim to eliminate HIV-AIDS from South-East Asia by 2015: WHO (Dec 1 is World AIDS Day) - Nov 30, 2011
- New HIV/AIDS study could turn treatment 'on its head' - Mar 04, 2011
Tags: boston university school, boston university school of medicine, developing world, drug regimen, drug resistant tb, edward jones, five patients, hiv therapy, multi drug resistant tb, open access, plos medicine, poor adherence, rapid diagnostics, school of medicine, tb disease, tb treatment, three decades, treatment regimen, tuberculosis tb, world health organisation